Targeted Clinical Trials for Antimicrobial Resistance
$4,985,063N01FY2017AINIH
Children'S Hosp Of Philadelphia, Philadelphia PA
Investigators
Abstract
To evaluate strategies that test the safety and effectiveness of therapeutic approaches/regimens to reduce the probability of the emergence of antibiotic drug resistance by minimizing unnecessary drug exposure. Specific aims include clinical trials for gram negative infections (urinary tract infections) in pediatric populations, designed to reduce antibiotic drug resistance.
View original record on NIH RePORTER →